title: David D. Derse, 1949-2009.
abstract: David D. Derse, Ph.D., Head of the Retrovirus Gene Expression Section in the HIV Drug Resistance Program at the National Cancer Institute-Frederick (NCI-Frederick), passed away on October 9, 2009, a scant six weeks after being diagnosed with liver cancer. It was with great sadness that family, friends, and colleagues gathered together for his memorial service on Saturday, October 17, 2009, at the Middletown United Methodist Church in Maryland. As a NCI scientist since 1986, Dave studied the molecular mechanisms of infection and replication of a number of different types of retroviruses. Dave became an internationally known expert on human T cell lymphotrophic viruses type 1 and 2 (HTLV-1 and HTLV-2) and served on the editorial boards of Virology and Retrovirology. His most recent studies focused on the mechanisms of HTLV-1 virion morphogenesis, transmission, and replication.
authors: Division of Basic Pharmaceutical Sciences, College of Pharmacy, Xavier University of Louisiana, New Orleans, LA 70125, USA. mshuh@xula.edu
authors: Maureen
authors: M
authors: Shuh
mesh_terms: D006800:Deltaretrovirus Infections / Q000635:transmission / Q000821:virology*; D049673:History, 20th Century; D049674:History, 21st Century; D015368:Human T-lymphotropic virus 1 / Q000502:physiology; D015367:Human T-lymphotropic virus 2 / Q000502:physiology; D006801:Humans; D008297:Male; D008396:Maryland; D010506:Periodicals as Topic; D014773:Virology / Q000266:history*; D014779:Virus Replication